As global markets navigate a landscape of mixed economic signals and geopolitical uncertainties, investors are increasingly looking toward Asia for opportunities. In this context, dividend stocks in Asia, particularly those yielding over 3.8%, can offer a compelling mix of income and potential stability amidst market fluctuations.

Top 10 Dividend Stocks In Asia

Name Dividend Yield Dividend Rating Wuliangye YibinLtd (SZSE:000858) 3.84% ★★★★★★ Chongqing Rural Commercial Bank (SEHK:3618) 7.98% ★★★★★★ CAC Holdings (TSE:4725) 4.87% ★★★★★★ Tsubakimoto Chain (TSE:6371) 4.10% ★★★★★★ Daito Trust ConstructionLtd (TSE:1878) 4.01% ★★★★★★ Intelligent Wave (TSE:4847) 3.77% ★★★★★★ China South Publishing & Media Group (SHSE:601098) 4.20% ★★★★★★ Guangxi LiuYao Group (SHSE:603368) 3.29% ★★★★★★ DoshishaLtd (TSE:7483) 3.74% ★★★★★★ E J Holdings (TSE:2153) 4.78% ★★★★★★

Click here to see the full list of 1133 stocks from our Top Asian Dividend Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

CMOC Group

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: CMOC Group Limited operates in the mining, beneficiation, smelting, and refining of base and rare metals with a market capitalization of approximately HK$175.53 billion.

Operations: CMOC Group Limited generates its revenue from the mining, beneficiation, smelting, and refining of base and rare metals.

Dividend Yield: 4.1%

CMOC Group's dividend payments have increased over the past decade and are well-covered by earnings, with a payout ratio of 40.3%, and cash flows, with a cash payout ratio of 19.8%. Despite its volatile dividend history, recent increases in dividends reflect improved financial performance, supported by significant earnings growth driven by higher output and sales of copper and cobalt products. The stock trades at a value below fair estimates but offers a lower yield compared to top-tier Hong Kong market payers.

Click here and access our complete dividend analysis report to understand the dynamics of CMOC Group. Our expertly prepared valuation report CMOC Group implies its share price may be lower than expected.SEHK:3993 Dividend History as at Mar 2025

MeiHua Holdings GroupLtd

Simply Wall St Dividend Rating: ★★★★★☆

Overview: MeiHua Holdings Group Co., Ltd is a synthetic biology company that offers amino acid nutrition and health solutions both in China and internationally, with a market cap of CN¥30.01 billion.

Operations: MeiHua Holdings Group Co., Ltd generates its revenue primarily from two segments: Medicine and Health, contributing CN¥476.31 million, and Biological Fermentation, which accounts for CN¥24.40 billion.

Story Continues

Dividend Yield: 5.7%

MeiHua Holdings Group Ltd.'s dividend yield is among the top 25% in China, supported by a payout ratio of 63.5% and a cash payout ratio of 64.9%. However, its dividend history has been unstable and unreliable over the past decade despite recent growth. The company faces challenges with declining earnings and revenue, as seen in its latest financial results, alongside legal settlements impacting financial resources. Nonetheless, it trades below estimated fair value compared to industry peers.

Dive into the specifics of MeiHua Holdings GroupLtd here with our thorough dividend report. Our valuation report here indicates MeiHua Holdings GroupLtd may be undervalued.SHSE:600873 Dividend History as at Mar 2025

Boai NKY Medical Holdings

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Boai NKY Medical Holdings Ltd. operates in the fine chemical and medical care sectors both in China and internationally, with a market cap of CN¥8.36 billion.

Operations: Boai NKY Medical Holdings Ltd. generates revenue through its operations in the fine chemical and medical care sectors, serving both domestic and international markets.

Dividend Yield: 3.9%

Boai NKY Medical Holdings offers a dividend yield of 3.87%, placing it in the top 25% of Chinese dividend payers. However, its dividends are not well covered by free cash flow, with a high cash payout ratio of 258.4%. Although current earnings cover the payout ratio at 77%, past payments have been volatile and unreliable, experiencing significant annual drops. The stock's price-to-earnings ratio of 20.9x is below the market average, indicating potential value for investors seeking entry points in dividend stocks.

Click here to discover the nuances of Boai NKY Medical Holdings with our detailed analytical dividend report. Upon reviewing our latest valuation report, Boai NKY Medical Holdings' share price might be too optimistic.SZSE:300109 Dividend History as at Mar 2025

Make It Happen

Take a closer look at our Top Asian Dividend Stocks list of 1133 companies by clicking here. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Ready To Venture Into Other Investment Styles?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SEHK:3993 SHSE:600873 and SZSE:300109.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments